Role of dopamine transporter imaging in routine clinical practice
Identifieur interne : 003F52 ( Main/Exploration ); précédent : 003F51; suivant : 003F53Role of dopamine transporter imaging in routine clinical practice
Auteurs : Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-12.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Aged, Alzheimer Disease (diagnosis), Alzheimer Disease (metabolism), Alzheimer Disease (physiopathology), Atypical, Biological transport, Brain (metabolism), Brain (pathology), Brain (physiopathology), Brain (radionuclide imaging), Case study, Caudate Nucleus (radionuclide imaging), Cocaine (analogs & derivatives), Cocaine (diagnostic use), Cocaine (pharmacokinetics), Corpus Striatum (radionuclide imaging), DAT imaging, Diagnosis, Diagnosis, Differential, Differential diagnostic, Dominance, Cerebral (physiology), Dopamine, Dopamine (analysis), Dopamine Plasma Membrane Transport Proteins, Essential Tremor (diagnosis), Essential Tremor (etiology), Essential Tremor (metabolism), Essential Tremor (physiopathology), Essential Tremor (radionuclide imaging), Female, Human, Humans, Indication, Iodine Radioisotopes (diagnostic use), Iodine Radioisotopes (pharmacokinetics), Lewy Body Disease (diagnosis), Lewy Body Disease (metabolism), Lewy Body Disease (physiopathology), Male, Membrane Glycoproteins, Membrane Transport Proteins (metabolism), Membrane Transport Proteins (physiology), Middle Aged, Nerve Tissue Proteins, Neural Pathways (radionuclide imaging), Organotechnetium Compounds (diagnostic use), Organotechnetium Compounds (pharmacokinetics), Parkinson Disease (diagnosis), Parkinson Disease (metabolism), Parkinson Disease (physiopathology), Parkinson Disease (radionuclide imaging), Parkinson disease, Parkinson's disease, Parkinsonism, Physician's Practice Patterns, Positron emission tomography, Putamen (radionuclide imaging), Radiopharmaceuticals (diagnostic use), Radiopharmaceuticals (pharmacokinetics), SPECT, Sensitivity and Specificity, Single photon emission tomography, Spinocerebellar Degenerations (radionuclide imaging), Substantia Nigra (radionuclide imaging), Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed, Tremor, Tropanes (diagnostic use), Tropanes (pharmacokinetics), atypical tremor disorders, diagnosis, dopamine transporter, emission computed, essential tremor, tomography.
- MESH :
- chemical , analogs & derivatives : Cocaine.
- chemical , analysis : Dopamine.
- diagnosis : Alzheimer Disease, Essential Tremor, Lewy Body Disease, Parkinson Disease.
- chemical , diagnostic use : Cocaine, Iodine Radioisotopes, Organotechnetium Compounds, Radiopharmaceuticals, Tropanes.
- etiology : Essential Tremor.
- metabolism : Alzheimer Disease, Brain, Essential Tremor, Lewy Body Disease, Membrane Transport Proteins, Parkinson Disease.
- pathology : Brain.
- chemical , pharmacokinetics : Cocaine, Iodine Radioisotopes, Organotechnetium Compounds, Radiopharmaceuticals, Tropanes.
- chemical , physiology : Dominance, Cerebral, Membrane Transport Proteins.
- physiopathology : Alzheimer Disease, Brain, Essential Tremor, Lewy Body Disease, Parkinson Disease.
- radionuclide imaging : Brain, Caudate Nucleus, Corpus Striatum, Essential Tremor, Neural Pathways, Parkinson Disease, Putamen, Spinocerebellar Degenerations, Substantia Nigra.
- chemical : Aged, Diagnosis, Differential, Dopamine Plasma Membrane Transport Proteins, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Physician's Practice Patterns, Sensitivity and Specificity, Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed.
Abstract
Functional imaging of the dopamine transporter (DAT) defines integrity of the dopaminergic system and has its main clinical application in patients with mild, incomplete, or uncertain parkinsonism. Imaging with specific single positron emission computerised tomography ligands for DAT (FP‐CIT, β‐CIT, IPT, TRODAT) provides a marker for presynaptic neuronal degeneration. Striatal uptake correlates with disease severity, in particular bradykinesia and rigidity, and monitoring of progression assists in clinical trials of potential neuroprotective drugs. DAT imaging is abnormal in idiopathic Parkinson's disease, multiple system atrophy and progressive supranuclear palsy and does not distinguish between these disorders. Dopamine loss is seen even in the earliest clinical presentations of true parkinsonism; a normal scan suggests an alternative diagnosis such as essential tremor, vascular parkinsonism (unless there is focal basal ganglia infarction), drug‐induced parkinsonism, or psychogenic parkinsonism. Congruence between working clinical diagnosis and DAT imaging increases over time in favour of baseline DAT imaging results. Additional applications are characterising dementia with parkinsonian features (abnormal results in dementia with Lewy bodies, normal in Alzheimer's disease); and differentiating juvenile‐onset Parkinson's disease (abnormal DAT) from dopa‐responsive dystonia (normal DAT). © 2003 Movement Disorder Society
Url:
- https://api.istex.fr/document/516974B861F0EB8DB9A7DA5A786468D824F38F88/fulltext/pdf
- https://api.istex.fr/document/124F0DD4D25D764CC546AC394C3FEEB9EE2B5157/fulltext/pdf
DOI: 10.1002/mds.10592
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001025
- to stream Istex, to step Curation: 001025
- to stream Istex, to step Checkpoint: 002882
- to stream PubMed, to step Corpus: 003611
- to stream PubMed, to step Curation: 003611
- to stream PubMed, to step Checkpoint: 003648
- to stream Ncbi, to step Merge: 000C53
- to stream Ncbi, to step Curation: 000C53
- to stream Ncbi, to step Checkpoint: 000C53
- to stream Main, to step Merge: 005B75
- to stream PascalFrancis, to step Corpus: 002330
- to stream PascalFrancis, to step Curation: 000991
- to stream PascalFrancis, to step Checkpoint: 002332
- to stream Main, to step Merge: 005E78
- to stream PascalFrancis, to step Corpus: 002351
- to stream PascalFrancis, to step Curation: 000970
- to stream PascalFrancis, to step Checkpoint: 002331
- to stream Main, to step Merge: 005E77
- to stream Istex, to step Corpus: 002C58
- to stream Istex, to step Curation: 002C58
- to stream Istex, to step Checkpoint: 002881
- to stream PubMed, to step Corpus: 003682
- to stream PubMed, to step Curation: 003682
- to stream PubMed, to step Checkpoint: 003647
- to stream Ncbi, to step Merge: 000B82
- to stream Ncbi, to step Curation: 000B82
- to stream Ncbi, to step Checkpoint: 000B82
- to stream Main, to step Merge: 005B74
- to stream Main, to step Curation: 003F52
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of dopamine transporter imaging in routine clinical practice</title>
<author><name sortKey="Marshall, Vicky" sort="Marshall, Vicky" uniqKey="Marshall V" first="Vicky" last="Marshall">Vicky Marshall</name>
</author>
<author><name sortKey="Grosset, Donald" sort="Grosset, Donald" uniqKey="Grosset D" first="Donald" last="Grosset">Donald Grosset</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:516974B861F0EB8DB9A7DA5A786468D824F38F88</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10592</idno>
<idno type="url">https://api.istex.fr/document/516974B861F0EB8DB9A7DA5A786468D824F38F88/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001025</idno>
<idno type="wicri:Area/Istex/Curation">001025</idno>
<idno type="wicri:Area/Istex/Checkpoint">002882</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Marshall V:role:of:dopamine</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14673877</idno>
<idno type="wicri:Area/PubMed/Corpus">003611</idno>
<idno type="wicri:Area/PubMed/Curation">003611</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003648</idno>
<idno type="wicri:Area/Ncbi/Merge">000C53</idno>
<idno type="wicri:Area/Ncbi/Curation">000C53</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C53</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Marshall V:role:of:dopamine</idno>
<idno type="wicri:Area/Main/Merge">005B75</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0129340</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002330</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000991</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002332</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Marshall V:role:of:dopamine</idno>
<idno type="wicri:Area/Main/Merge">005E78</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0115366</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002351</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000970</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002331</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Marshall V:role:of:dopamine</idno>
<idno type="wicri:Area/Main/Merge">005E77</idno>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:124F0DD4D25D764CC546AC394C3FEEB9EE2B5157</idno>
<idno type="url">https://api.istex.fr/document/124F0DD4D25D764CC546AC394C3FEEB9EE2B5157/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C58</idno>
<idno type="wicri:Area/Istex/Curation">002C58</idno>
<idno type="wicri:Area/Istex/Checkpoint">002881</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Marshall V:role:of:dopamine</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14531042</idno>
<idno type="wicri:Area/PubMed/Corpus">003682</idno>
<idno type="wicri:Area/PubMed/Curation">003682</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003647</idno>
<idno type="wicri:Area/Ncbi/Merge">000B82</idno>
<idno type="wicri:Area/Ncbi/Curation">000B82</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B82</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Marshall V:role:of:dopamine</idno>
<idno type="wicri:Area/Main/Merge">005B74</idno>
<idno type="wicri:Area/Main/Curation">003F52</idno>
<idno type="wicri:Area/Main/Exploration">003F52</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Role of dopamine transporter imaging in routine clinical practice</title>
<author><name sortKey="Marshall, Vicky" sort="Marshall, Vicky" uniqKey="Marshall V" first="Vicky" last="Marshall">Vicky Marshall</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Neurological Sciences, Glasgow</wicri:regionArea>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grosset, Donald" sort="Grosset, Donald" uniqKey="Grosset D" first="Donald" last="Grosset">Donald Grosset</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Neurological Sciences, Glasgow</wicri:regionArea>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-12">2003-12</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1415">1415</biblScope>
<biblScope unit="page" to="1423">1423</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">516974B861F0EB8DB9A7DA5A786468D824F38F88</idno>
<idno type="DOI">10.1002/mds.10592</idno>
<idno type="ArticleID">MDS10592</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Alzheimer Disease (diagnosis)</term>
<term>Alzheimer Disease (metabolism)</term>
<term>Alzheimer Disease (physiopathology)</term>
<term>Atypical</term>
<term>Biological transport</term>
<term>Brain (metabolism)</term>
<term>Brain (pathology)</term>
<term>Brain (physiopathology)</term>
<term>Brain (radionuclide imaging)</term>
<term>Case study</term>
<term>Caudate Nucleus (radionuclide imaging)</term>
<term>Cocaine (analogs & derivatives)</term>
<term>Cocaine (diagnostic use)</term>
<term>Cocaine (pharmacokinetics)</term>
<term>Corpus Striatum (radionuclide imaging)</term>
<term>DAT imaging</term>
<term>Diagnosis</term>
<term>Diagnosis, Differential</term>
<term>Differential diagnostic</term>
<term>Dominance, Cerebral (physiology)</term>
<term>Dopamine</term>
<term>Dopamine (analysis)</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Essential Tremor (diagnosis)</term>
<term>Essential Tremor (etiology)</term>
<term>Essential Tremor (metabolism)</term>
<term>Essential Tremor (physiopathology)</term>
<term>Essential Tremor (radionuclide imaging)</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Indication</term>
<term>Iodine Radioisotopes (diagnostic use)</term>
<term>Iodine Radioisotopes (pharmacokinetics)</term>
<term>Lewy Body Disease (diagnosis)</term>
<term>Lewy Body Disease (metabolism)</term>
<term>Lewy Body Disease (physiopathology)</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins (metabolism)</term>
<term>Membrane Transport Proteins (physiology)</term>
<term>Middle Aged</term>
<term>Nerve Tissue Proteins</term>
<term>Neural Pathways (radionuclide imaging)</term>
<term>Organotechnetium Compounds (diagnostic use)</term>
<term>Organotechnetium Compounds (pharmacokinetics)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (radionuclide imaging)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Parkinsonism</term>
<term>Physician's Practice Patterns</term>
<term>Positron emission tomography</term>
<term>Putamen (radionuclide imaging)</term>
<term>Radiopharmaceuticals (diagnostic use)</term>
<term>Radiopharmaceuticals (pharmacokinetics)</term>
<term>SPECT</term>
<term>Sensitivity and Specificity</term>
<term>Single photon emission tomography</term>
<term>Spinocerebellar Degenerations (radionuclide imaging)</term>
<term>Substantia Nigra (radionuclide imaging)</term>
<term>Tomography, Emission-Computed</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Tomography, X-Ray Computed</term>
<term>Tremor</term>
<term>Tropanes (diagnostic use)</term>
<term>Tropanes (pharmacokinetics)</term>
<term>atypical tremor disorders</term>
<term>diagnosis</term>
<term>dopamine transporter</term>
<term>emission computed</term>
<term>essential tremor</term>
<term>tomography</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Cocaine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Alzheimer Disease</term>
<term>Essential Tremor</term>
<term>Lewy Body Disease</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Cocaine</term>
<term>Iodine Radioisotopes</term>
<term>Organotechnetium Compounds</term>
<term>Radiopharmaceuticals</term>
<term>Tropanes</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Essential Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Alzheimer Disease</term>
<term>Brain</term>
<term>Essential Tremor</term>
<term>Lewy Body Disease</term>
<term>Membrane Transport Proteins</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Cocaine</term>
<term>Iodine Radioisotopes</term>
<term>Organotechnetium Compounds</term>
<term>Radiopharmaceuticals</term>
<term>Tropanes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Dominance, Cerebral</term>
<term>Membrane Transport Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Alzheimer Disease</term>
<term>Brain</term>
<term>Essential Tremor</term>
<term>Lewy Body Disease</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Brain</term>
<term>Caudate Nucleus</term>
<term>Corpus Striatum</term>
<term>Essential Tremor</term>
<term>Neural Pathways</term>
<term>Parkinson Disease</term>
<term>Putamen</term>
<term>Spinocerebellar Degenerations</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Aged</term>
<term>Diagnosis, Differential</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Middle Aged</term>
<term>Nerve Tissue Proteins</term>
<term>Physician's Practice Patterns</term>
<term>Sensitivity and Specificity</term>
<term>Tomography, Emission-Computed</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Atypique</term>
<term>Diagnostic</term>
<term>Diagnostic différentiel</term>
<term>Dopamine</term>
<term>Etude cas</term>
<term>Homme</term>
<term>Indication</term>
<term>Parkinson maladie</term>
<term>Parkinsonisme</term>
<term>Tomographie émission positon</term>
<term>Tomoscintigraphie émission monophotonique</term>
<term>Transport biologique</term>
<term>Tremblement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Functional imaging of the dopamine transporter (DAT) defines integrity of the dopaminergic system and has its main clinical application in patients with mild, incomplete, or uncertain parkinsonism. Imaging with specific single positron emission computerised tomography ligands for DAT (FP‐CIT, β‐CIT, IPT, TRODAT) provides a marker for presynaptic neuronal degeneration. Striatal uptake correlates with disease severity, in particular bradykinesia and rigidity, and monitoring of progression assists in clinical trials of potential neuroprotective drugs. DAT imaging is abnormal in idiopathic Parkinson's disease, multiple system atrophy and progressive supranuclear palsy and does not distinguish between these disorders. Dopamine loss is seen even in the earliest clinical presentations of true parkinsonism; a normal scan suggests an alternative diagnosis such as essential tremor, vascular parkinsonism (unless there is focal basal ganglia infarction), drug‐induced parkinsonism, or psychogenic parkinsonism. Congruence between working clinical diagnosis and DAT imaging increases over time in favour of baseline DAT imaging results. Additional applications are characterising dementia with parkinsonian features (abnormal results in dementia with Lewy bodies, normal in Alzheimer's disease); and differentiating juvenile‐onset Parkinson's disease (abnormal DAT) from dopa‐responsive dystonia (normal DAT). © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Marshall, Vicky" sort="Marshall, Vicky" uniqKey="Marshall V" first="Vicky" last="Marshall">Vicky Marshall</name>
</noRegion>
<name sortKey="Grosset, Donald" sort="Grosset, Donald" uniqKey="Grosset D" first="Donald" last="Grosset">Donald Grosset</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:516974B861F0EB8DB9A7DA5A786468D824F38F88 |texte= Role of dopamine transporter imaging in routine clinical practice }}
This area was generated with Dilib version V0.6.23. |